Neil Martinson to Pre-Exposure Prophylaxis
This is a "connection" page, showing publications Neil Martinson has written about Pre-Exposure Prophylaxis.
Connection Strength
1,483
-
Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis. Front Immunol. 2024; 15:1415475.
Score: 0,189
-
A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe. PLoS One. 2023; 18(6):e0287627.
Score: 0,172
-
Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial. EBioMedicine. 2023 Jul; 93:104648.
Score: 0,172
-
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin. AIDS. 2023 09 01; 37(11):1651-1659.
Score: 0,172
-
Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa. Front Immunol. 2022; 13:1009978.
Score: 0,165
-
A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe. J Int AIDS Soc. 2022 08; 25(8):e25975.
Score: 0,162
-
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa. Front Immunol. 2022; 13:965214.
Score: 0,162
-
A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa. BMC Health Serv Res. 2021 Jan 06; 21(1):17.
Score: 0,145
-
Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial. Trials. 2020 Oct 30; 21(1):900.
Score: 0,143